Monopar Therapeutics (MNPR) Misses Q1 EPS by 46c

Monopar Therapeutics (NASDAQ: MNPR) reported Q1 EPS of ($0.46).

For earnings history and earnings-related data on Monopar Therapeutics (MNPR) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings